D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Apple
AAPL
|
+$392M |
| 2 |
Starbucks
SBUX
|
+$370M |
| 3 |
Pfizer
PFE
|
+$338M |
| 4 |
PayPal
PYPL
|
+$320M |
| 5 |
Charles Schwab
SCHW
|
+$305M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$415M |
| 4 |
Citigroup
C
|
+$312M |
| 5 |
Booking.com
BKNG
|
+$289M |
Sector Composition
| 1 | Technology | 19.01% |
| 2 | Consumer Discretionary | 12.74% |
| 3 | Financials | 11.39% |
| 4 | Healthcare | 11.24% |
| 5 | Energy | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
APTO
3076
DELISTED
Aptose Biosciences, Inc.
APTO
| $480K | ﹤0.01% |
784
+197
| +34% | +$121K |
|
3077
UiPath
PATH
$6.1B
| $479K | ﹤0.01% |
+22,178
| New | +$479K |
|
3078
KB Home
KBH
$4.48B
| $477K | ﹤0.01% |
14,730
+9,924
| +206% | +$321K |
|
|
CTOS.WS
3079
DELISTED
Custom Truck One Source, Inc. Warrants, exerciseable for Common Stock
CTOS.WS
| $477K | ﹤0.01% |
216,666
| – | – |
|
3080
Invesco Mortgage Capital
IVR
$502M
| $475K | ﹤0.01% |
20,835
-17,648
| -46% | -$402K |
|
3081
Archer Aviation
ACHR
$5.64B
| $474K | ﹤0.01% |
98,447
-155,387
| -61% | -$748K |
|
3082
PennyMac Financial
PFSI
$6.44B
| $473K | ﹤0.01% |
8,893
-111,568
| -93% | -$5.93M |
|
3083
Shattuck Labs
STTK
$92M
| $472K | ﹤0.01% |
110,826
+60,134
| +119% | +$256K |
|
3084
American Financial Group
AFG
$11.7B
| $471K | ﹤0.01% |
3,233
-4,162
| -56% | -$606K |
|
|
AAN
3085
DELISTED
The Aaron's Company, Inc.
AAN
| $471K | ﹤0.01% |
23,452
+13,256
| +130% | +$266K |
|
|
BRSL
3086
Brightstar Lottery PLC
BRSL
$3.12B
| $469K | ﹤0.01% |
18,984
-500
| -3% | -$12.4K |
|
3087
Xencor
XNCR
$613M
| $468K | ﹤0.01% |
+17,559
| New | +$468K |
|
|
HMTV
3088
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $468K | ﹤0.01% |
102,331
+6,676
| +7% | +$30.5K |
|
3089
Alamo Group
ALG
$2.49B
| $467K | ﹤0.01% |
3,247
+1,507
| +87% | +$217K |
|
|
REV
3090
DELISTED
Revlon, Inc.
REV
| $466K | ﹤0.01% |
57,753
-76,699
| -57% | -$619K |
|
|
GBT
3091
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $464K | ﹤0.01% |
13,402
-13,421
| -50% | -$465K |
|
3092
Kadant
KAI
$3.69B
| $463K | ﹤0.01% |
2,384
-93
| -4% | -$18.1K |
|
3093
S&T Bancorp
STBA
$1.5B
| $463K | ﹤0.01% |
15,639
+261
| +2% | +$7.73K |
|
3094
Universal Logistics Holdings
ULH
$650M
| $462K | ﹤0.01% |
22,949
-7,705
| -25% | -$155K |
|
|
MORF
3095
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $461K | ﹤0.01% |
11,476
-14,300
| -55% | -$574K |
|
|
AGRX
3096
DELISTED
Agile Therapeutics, Inc
AGRX
| $460K | ﹤0.01% |
1,099
+18
| +2% | +$7.53K |
|
3097
CytomX Therapeutics
CTMX
$330M
| $454K | ﹤0.01% |
+169,951
| New | +$454K |
|
3098
Immuneering
IMRX
$353M
| $454K | ﹤0.01% |
+70,127
| New | +$454K |
|
3099
Tenaya Therapeutics
TNYA
$196M
| $454K | ﹤0.01% |
+38,516
| New | +$454K |
|
3100
Eos Energy Enterprises
EOSE
$2.29B
| $453K | ﹤0.01% |
108,372
+94,658
| +690% | +$396K |
|